Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

T cells subtypes in pleural effusion of tuberculous and non-tuberculous patients

Neda Dalil Roofchayee, Majid Marjani, Neda K.Dezfuli, Esmaeil Mortaz
European Respiratory Journal 2021 58: PA3089; DOI: 10.1183/13993003.congress-2021.PA3089
Neda Dalil Roofchayee
1Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: n_dalil92@yahoo.com
Majid Marjani
2Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neda K.Dezfuli
1Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esmaeil Mortaz
3Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences., Tehran, Islamic Republic of Iran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Background: Tuberculous pleural effusion (TPE) is one of the most common forms of extrapulmonary tuberculosis. Patients with tuberculous or malignant pleural effusions (MPE) frequently have similar lymphocytic pleural fluid profile.

Objective: We aimed to determine whether T helper (Th) subsets able to differentiates TPE from non-TPE patients.

Methods: 30 patients with TPE, 30 patients with MPE, 14 patients with EMP and 14 patients with PPE were enrolled between Dec 2018-2019, Tehran-Iran. 3 ml fresh PE harvested and after staining with related Abs, the frequency of T cells phenotypes; CD4+IL-9+, CD4+IL-22+, CD+IL-17+ and CD4+CD25+FOXP3+T cells were determined by flowcytometry.

Results: D4+CD25+FOXP3+ T cells were detected as important markers for TPE (P<0.0001). There were a significant differences in of CD4+IL-9+ T cells in TPE in compared to non-TPE (P<0.0001). But, the frequency of CD+IL-17+ and CD4+IL-22+ T cells had no significant difference between TPE and non-TPE patients (P=0.0906 and P=0.2188, respectively).

Conclusion: The current data suggests that high frequency of CD4+CD25+FOXP3+ T cells may differentiates TPE from non-TPE and future studies with multicenter studies is needed for generalize this finding as a biomarkers.

T cell subtypesTPENon-TPEP value
CD4+IL-9+ (%)

3.67 ( 0.87 – 47.83)

13.05 (1.67 – 61.45)< 0.0001
CD4+IL-17+ (%)7.15(1.118– 9.43)15.05 (1.195 -66.55)0.0906
CD4+IL-22+ (%)0.2 (0.185 – 61.75)11.8 (1.119 – 70.5)0.2188
CD4+CD25+FOXP3+ (%)4.2 (0.362-17.24)26.3 (3.349 – 76.93)<0.0001
  • Immunology

Footnotes

Cite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3089.

This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2021
Previous
Back to top
Vol 58 Issue suppl 65 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
T cells subtypes in pleural effusion of tuberculous and non-tuberculous patients
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
T cells subtypes in pleural effusion of tuberculous and non-tuberculous patients
Neda Dalil Roofchayee, Majid Marjani, Neda K.Dezfuli, Esmaeil Mortaz
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3089; DOI: 10.1183/13993003.congress-2021.PA3089

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
T cells subtypes in pleural effusion of tuberculous and non-tuberculous patients
Neda Dalil Roofchayee, Majid Marjani, Neda K.Dezfuli, Esmaeil Mortaz
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3089; DOI: 10.1183/13993003.congress-2021.PA3089
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • LTBI - MDR/XDR-TB cases - should all be treated?
  • Clinical and mutational profile of extensively drug resistant tuberculosis cases in northern India
  • Efficacy of linezolide-free chemotherapy schemes in patients with highly drug-resistant tuberculosis
Show more Tuberculosis and non-tuberculous mycobacterial diseases

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society